Parabacteroides distasonis-Derived Outer Membrane Vesicles Enhance Antitumor Immunity Against Colon Tumors by Modulating CXCL10 and CD8⁺ T Cells

References

• Kim BJ, Hanna MH. Colorectal cancer in young adults. J Surg Oncol. 2023;127(8):1247–1251. doi:10.1002/jso.27320
   PubMed Web of Science ®Google Scholar
• Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–254. doi:10.3322/caac.21772
   PubMed Web of Science ®Google Scholar
• Puzzono M, Mannucci A, Grannò S, et al. The role of diet and lifestyle in early-onset colorectal cancer: a systematic review. Cancers. 2021;13(23):5933. doi:10.3390/cancers13235933
   PubMed Web of Science ®Google Scholar
• Kumar R, Harilal S, Carradori S, Mathew B. A comprehensive overview of colon cancer- a grim reaper of the 21st century. Curr Med Chem. 2021;28(14):2657–2696. doi:10.2174/0929867327666201026143757
   PubMed Web of Science ®Google Scholar
• Kim JH. Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015;21(17):5158–5166. doi:10.3748/wjg.v21.i17.5158
   PubMed Web of Science ®Google Scholar
• Kang Y, Li S. Nanomaterials: breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol. 2023;230:123159. doi:10.1016/j.ijbiomac.2023.123159
   PubMed Web of Science ®Google Scholar
• WU WK. Parabacteroides distasonis: an emerging probiotic? Gut. 2023;72(9):1635–1636. doi:10.1136/gutjnl-2022-329386
   PubMed Web of Science ®Google Scholar
• Ezeji JC, Sarikonda DK, Hopperton A, et al. Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. Gut Microbes. 2021;13(1):1922241. doi:10.1080/19490976.2021.1922241
   PubMed Web of Science ®Google Scholar
• Wang K, Liao M, Zhou N, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26(1):222–235. doi:10.1016/j.celrep.2018.12.028
   PubMed Web of Science ®Google Scholar
• Cuffaro B, Assohoun ALW, Boutillier D, et al. In vitro characterization of gut microbiota-derived commensal strains: selection of Parabacteroides distasonis strains alleviating TNBS-induced colitis in mice. Cells. 2020;9(9):2104. doi:10.3390/cells9092104
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang S, Li S, et al. Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier. BMC Biol. 2023;21(1):90. doi:10.1186/s12915-023-01578-2
   PubMed Web of Science ®Google Scholar
• Sun H, Guo Y, Wang H, et al. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. Gut. 2023;72(9):1664–1677. doi:10.1136/gutjnl-2022-327756
   PubMed Web of Science ®Google Scholar
• Zhao Q, Dai MY, Huang RY, et al. Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. Nat Commun. 2023;14(1):1829. doi:10.1038/s41467-023-37459-z
   PubMed Web of Science ®Google Scholar
• Koh GY, Kane A, Lee K, et al. Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int, J, Cancer. 2018;143(7):1797–1805. doi:10.1002/ijc.31559
   PubMed Web of Science ®Google Scholar
• Koh GY, Kane AV, Wu X, Crott JW. Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A/J mice. Carcinogenesis. 2020;41(7):909–917. doi:10.1093/carcin/bgaa018
   PubMed Web of Science ®Google Scholar
• Huang X, Pan J, Xu F, et al. Bacteria-based cancer immunotherapy. Adv Sci. 2021;8(7):2003572. doi:10.1002/advs.202003572
   Web of Science ®Google Scholar
• Weng Z, Yang N, Shi S, et al. Outer membrane vesicles from Acinetobacter baumannii: biogenesis, functions, and vaccine application. Vaccines. 2023;12(1):49. doi:10.3390/vaccines12010049
   Web of Science ®Google Scholar
• Li M, Zhou H, Yang C, et al. Bacterial outer membrane vesicles as a platform for biomedical applications: an update. J Control Release. 2020;323:253–268. doi:10.1016/j.jconrel.2020.04.031
   PubMed Web of Science ®Google Scholar
• Li P, Peng T, Xiang T, et al. Klebsiella pneumoniae outer membrane vesicles induce strong IL-8 expression via NF-κB activation in normal pulmonary bronchial cells. Int Immunopharmacol. 2023;121:110352. doi:10.1016/j.intimp.2023.110352
   PubMed Web of Science ®Google Scholar
• Liu G, Ma N, Cheng K, et al. Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity. Nat Nanotechnol. 2023;19(3):387–398. doi:10.1038/s41565-023-01553-6
   PubMed Web of Science ®Google Scholar
• Holst J, Oster P, Arnold R, et al. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother. 2013;9(6):1241–1253. doi:10.4161/hv.24129
   PubMed Web of Science ®Google Scholar
• Won S, Lee C, Bae S, et al. Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8+ T cells which enables an effective combination immunotherapy with anti-PD-1. J Extracell Vesicles. 2023;12(8):e12357. doi:10.1002/jev2.12357
   PubMed Web of Science ®Google Scholar
• Kim OY, Park HT, Dinh NTH, et al. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nat Commun. 2017;8(1):626. doi:10.1038/s41467-017-00729-8
   PubMed Web of Science ®Google Scholar
• Alaniz RC, Deatherage BL, Lara JC, Cookson BT. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol. 2007;179(11):7692–7701. doi:10.4049/jimmunol.179.11.7692
   PubMed Web of Science ®Google Scholar
• Tong Q, Li K, Huang F, et al. Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy. Mater Today Bio. 2023;23:100845. doi:10.1016/j.mtbio.2023.100845
   PubMedGoogle Scholar
• Mehta JP, Ayakar S, Singhal RS. The potential of paraprobiotics and postbiotics to modulate the immune system: a review. Microbiol Res. 2023;275:127449. doi:10.1016/j.micres.2023.127449
   PubMedGoogle Scholar
• Chen Y, Xu Y, Zhong H, et al. Extracellular vesicles in Inter-Kingdom communication in gastrointestinal cancer. Am J Cancer Res. 2021;11(4):1087–1103.
   PubMed Web of Science ®Google Scholar
• Liu Y, Defourny KAY, Smid EJ, Abee T. Gram-positive bacterial extracellular vesicles and their impact on health and disease. Front Microbiol. 2018;9:1502. doi:10.3389/fmicb.2018.01502
   PubMed Web of Science ®Google Scholar
• Juodeikis R, Carding SR. Outer membrane vesicles: biogenesis, functions, and issues. Microbiol Mol Biol Rev. 2022;86(4):e0003222. doi:10.1128/mmbr.00032-22
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng J, Wang X, et al. Isolation, identification, and proteomic analysis of outer membrane vesicles of Riemerella anatipestifer SX-1. Poult Sci. 2024;103(6):103639. doi:10.1016/j.psj.2024.103639
   PubMed Web of Science ®Google Scholar
• Valencia-Lazcano AA, Hassan D, Pourmadadi M, et al. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur J Med Chem. 2023;246:114995. doi:10.1016/j.ejmech.2022.114995
   PubMed Web of Science ®Google Scholar
• Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296(5573):1634–1635. doi:10.1126/science.1071924
   PubMed Web of Science ®Google Scholar
• Kearney CJ, Vervoort SJ, Hogg SJ, et al. Tumor immune evasion arises through loss of TNF sensitivity. Sci Immunol. 2018;3(23):eaar3451. doi:10.1126/sciimmunol.aar3451
   PubMed Web of Science ®Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–572. doi:10.1038/nri.2017.49
   PubMed Web of Science ®Google Scholar
• Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996;184(3):963–969. doi:10.1084/jem.184.3.963
   PubMed Web of Science ®Google Scholar
• Weng Y, Siciliano SJ, Waldburger KE, et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998;273(29):18288–18291. doi:10.1074/jbc.273.29.18288
   PubMed Web of Science ®Google Scholar
• Philip M, Schietinger A. CD8+ T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209–223. doi:10.1038/s41577-021-00574-3
   PubMed Web of Science ®Google Scholar
• Wang Q, Qin Y, Li B. CD8+ T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;559:216043. doi:10.1016/j.canlet.2022.216043
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Li W, Deng X, Chen T. Exploring the modulatory effects of gut microbiota in anti-cancer therapy. Front Oncol. 2021;11:644454. doi:10.3389/fonc.2021.644454
   PubMed Web of Science ®Google Scholar
• Zhao M, Chen X, Yang Z, Yang X, Peng Q. Bacteria and tumor: understanding the roles of bacteria in tumor genesis and immunology. Microbiol Res. 2022;261:127082. doi:10.1016/j.micres.2022.127082
   PubMedGoogle Scholar
• Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;3:22.
   PubMedGoogle Scholar
• Sartorio MG, Pardue EJ, Feldman MF, Haurat MF. Bacterial outer membrane vesicles: from discovery to applications. Annu Rev Microbiol. 2021;75(1):609–630. doi:10.1146/annurev-micro-052821-031444
   PubMedGoogle Scholar
• Zumwalt TJ, Arnold M, Goel A, Boland CR. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Oncotarget. 2015;6(5):2981–2991. doi:10.18632/oncotarget.3205
   PubMed Web of Science ®Google Scholar
• House IG, Savas P, Lai J, et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin Cancer Res. 2020;26(2):487–504. doi:10.1158/1078-0432.CCR-19-1868
   PubMed Web of Science ®Google Scholar
• Karin N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front Immunol. 2020;11:976. doi:10.3389/fimmu.2020.00976
   PubMed Web of Science ®Google Scholar
• Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–550. doi:10.1038/nrc1388
   PubMed Web of Science ®Google Scholar
• Li Z, Ma R, Tang H, et al. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell. 2024;187(3):624–641.e623. doi:10.1016/j.cell.2023.12.015
   PubMed Web of Science ®Google Scholar
• Barreira da Silva R, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol. 2015;16(8):850–858. doi:10.1038/ni.3201
   PubMed Web of Science ®Google Scholar
• Bronger H, Singer J, Windmüller C, et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br J Cancer. 2016;115(5):553–563. doi:10.1038/bjc.2016.172
   PubMed Web of Science ®Google Scholar
• Li X, Lu M, Yuan M, et al. CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy. Oncoimmunology. 2022;11(1):2118210. doi:10.1080/2162402X.2022.2118210
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang Z, Du J, et al. Recruiting T-cells toward the brain for enhanced glioblastoma immunotherapeutic efficacy by co-delivery of cytokines and immune checkpoint antibodies with macrophage-membrane-camouflaged nanovesicles. Adv Mater. 2023;35(25):e2209785.
   PubMed Web of Science ®Google Scholar
• Lu S, Xu J, Zhao Z, et al. Dietary Lactobacillus rhamnosus GG extracellular vesicles enhance antiprogrammed cell death 1 (anti-PD-1) immunotherapy efficacy against colorectal cancer. Food Funct. 2023;14(23):10314–10328. doi:10.1039/D3FO02018E
   PubMed Web of Science ®Google Scholar
• Xu W, Hao X, Li Y, et al. Safe induction of acute inflammation with enhanced antitumor immunity by hydrogel-mediated outer membrane vesicle delivery. Small Methods;2024. e2301620. doi:10.1002/smtd.202301620
   PubMed Web of Science ®Google Scholar
• Su LY, Tian Y, Zheng Q, et al. Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor. Cell Chem Biol. 2024;24:00038.
   Google Scholar
• Chen X, Li P, Luo B, et al. Surface mineralization of engineered bacterial outer membrane vesicles to enhance tumor photothermal/immunotherapy. ACS Nano. 2024;18(2):1357–1370. doi:10.1021/acsnano.3c05714
   PubMed Web of Science ®Google Scholar
• Qing S, Lyu C, Zhu L, et al. Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy. Adv Mater. 2020;32(47):e2002085.
   PubMed Web of Science ®Google Scholar
• Pan J, Li X, Shao B, et al. Self-blockade of PD-L1 with bacteria-derived outer-membrane vesicle for enhanced cancer immunotherapy. Adv Mater. 2022;34(7):e2106307. doi:10.1002/adma.202106307
   PubMed Web of Science ®Google Scholar
• Jiang S, Fu W, Wang S, Zhu G, Wang J, Ma Y. Bacterial outer membrane vesicles loaded with Perhexiline suppress tumor development by regulating tumor-associated macrophages repolarization in a synergistic way. Int J Mol Sci. 2023;24(13):11222. doi:10.3390/ijms241311222
   PubMed Web of Science ®Google Scholar
• Kuerban K, Gao X, Zhang H, et al. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm Sin B. 2020;10(8):1534–1548. doi:10.1016/j.apsb.2020.02.002
   PubMed Web of Science ®Google Scholar